Literature DB >> 28396494

Lipocalin-2 from both myeloid cells and the epithelium combats Klebsiella pneumoniae lung infection in mice.

Elisabeth P Cramer1, Sara L Dahl1, Björn Rozell2, Kasper J Knudsen3,4, Kim Thomsen5, Claus Moser5, Jack B Cowland1,6, Niels Borregaard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28396494     DOI： 10.1182/blood-2016-11-753434

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

Review 1.  Iron and infection.

Authors:  Tomas Ganz
Journal:  Int J Hematol       Date:  2017-11-16       Impact factor: 2.490

2.  Innate lymphoid cell type 3-derived interleukin-22 boosts lipocalin-2 production in intestinal epithelial cells via synergy between STAT3 and NF-κB.

Authors:  Maarten Coorens; Anna Rao; Stefanie Katharina Gräfe; Daniel Unelius; Ulrik Lindforss; Birgitta Agerberth; Jenny Mjösberg; Peter Bergman
Journal:  J Biol Chem       Date:  2019-02-19       Impact factor: 5.157

3.  Hepatocytes and neutrophils cooperatively suppress bacterial infection by differentially regulating lipocalin-2 and neutrophil extracellular traps.

Authors:  Hongjie Li; Dechun Feng; Yan Cai; Yudong Liu; Mingjiang Xu; Xiaogang Xiang; Zhou Zhou; Qiang Xia; Mariana J Kaplan; Xiaoni Kong; Bin Gao
Journal:  Hepatology       Date:  2018-05-10       Impact factor: 17.425

4.  Endothelial dysfunction is an early indicator of sepsis and neutrophil degranulation of septic shock in surgical patients.

Authors:  M Martin-Fernandez; L M Vaquero-Roncero; R Almansa; E Gómez-Sánchez; S Martín; E Tamayo; M C Esteban-Velasco; P Ruiz-Granado; M Aragón; D Calvo; J Rico-Feijoo; A Ortega; E Gómez-Pesquera; M Lorenzo-López; J López; C Doncel; C González-Sanchez; D Álvarez; E Zarca; A Ríos-Llorente; A Diaz-Alvarez; E Sanchez-Barrado; D Andaluz-Ojeda; J M Calvo-Vecino; L Muñoz-Bellvís; J I Gomez-Herreras; C Abad-Molina; J F Bermejo-Martin; C Aldecoa; M Heredia-Rodríguez
Journal:  BJS Open       Date:  2020-02-19

5.  Lipocalin-2 Functions as Inhibitor of Innate Resistance to Mycobacterium tuberculosis.

Authors:  Sara Louise Dahl; Joshua S Woodworth; Christian Johann Lerche; Elisabeth Præstekjær Cramer; Pia Rude Nielsen; Claus Moser; Allan Randrup Thomsen; Niels Borregaard; Jack Bernard Cowland
Journal:  Front Immunol       Date:  2018-11-26       Impact factor: 7.561

6.  Chronic Carbon Tetrachloride Applications Induced Hepatocyte Apoptosis in Lipocalin 2 Null Mice Through Endoplasmic Reticulum Stress and Unfolded Protein Response.

Authors:  Erawan Borkham-Kamphorst; Ute Haas; Eddy Van de Leur; Anothai Trevanich; Ralf Weiskirchen
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

7.  A neutrophil activation signature predicts critical illness and mortality in COVID-19.

Authors:  Matthew L Meizlish; Alexander B Pine; Jason D Bishai; George Goshua; Emily R Nadelmann; Michael Simonov; C-Hong Chang; Hanming Zhang; Marcus Shallow; Parveen Bahel; Kent Owusu; Yu Yamamoto; Tanima Arora; Deepak S Atri; Amisha Patel; Rana Gbyli; Jennifer Kwan; Christine H Won; Charles Dela Cruz; Christina Price; Jonathan Koff; Brett A King; Henry M Rinder; F Perry Wilson; John Hwa; Stephanie Halene; William Damsky; David van Dijk; Alfred I Lee; Hyung J Chun
Journal:  Blood Adv       Date:  2021-03-09

8.  Polyvalent Bacterial Lysate Protects Against Pneumonia Independently of Neutrophils, IL-17A or Caspase-1 Activation.

Authors:  Florencia Ferrara; Analía Rial; Norma Suárez; José Alejandro Chabalgoity
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

9.  Subtilase cytotoxin induces a novel form of Lipocalin 2, which promotes Shiga-toxigenic Escherichia coli survival.

Authors:  Kinnosuke Yahiro; Kohei Ogura; Yoshiyuki Goto; Sunao Iyoda; Tatsuya Kobayashi; Hiroki Takeuchi; Makoto Ohnishi; Joel Moss
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379

10.  Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development.

Authors:  Warapen Treekitkarnmongkol; Maya Hassane; Ansam Sinjab; Kyle Chang; Kieko Hara; Zahraa Rahal; Jiexin Zhang; Wei Lu; Smruthy Sivakumar; Tina L McDowell; Jacob Kantrowitz; Jianling Zhou; Wenhua Lang; Li Xu; Joshua K Ochieng; Sayuri Nunomura-Nakamura; Shanshan Deng; Carmen Behrens; Maria Gabriela Raso; Junya Fukuoka; Alexandre Reuben; Edwin J Ostrin; Edwin Parra; Luisa M Solis; Avrum E Spira; Florencia McAllister; Tina Cascone; Ignacio I Wistuba; Seyed Javad Moghaddam; Paul A Scheet; Junya Fujimoto; Humam Kadara
Journal:  Am J Respir Crit Care Med       Date:  2021-01-01       Impact factor: 21.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.